Stuart has over 15 years of pharma industry experience in commercial strategy, including new product planning and early commercialization, brand & lifecycle management strategy, and launch readiness.Since joining Guidehouse, he has supported clients in the pharmaceutical and biotech industries with asset & franchise strategy development, commercial and financial assessments for business development opportunities, as well as brand performance analysis.
Prior to Guidehouse, Stuart was the Vice President of Global Marketing for the Women’s Cancer & DDR Franchise in AZ. In this role he was accountable for shaping, driving and implementing global commercial strategy for the ovarian and breast cancer portfolios. Prior to AZ, Stuart spent 10 years at Roche/Genentech, in a variety of roles at both global and country levels, across all stages of the product lifecycle from Phase 0 through proof of concept and launch to product maturity.
Stuart has extensive experience in oncology and haematology, having worked in all major solid tumours and haematological malignancies. Stuart holds a BSc in Physiology & Pharmacology from Southampton University, an MBA from Henley Management College, and a PG Certificate in Health Economics from Aberdeen University.
M.B.A., Henley Business School, Oxfordshire, UK Postgraduate Certificate, Heath Economics, University of Aberdeen, Scotland B.Sc., with honors, Pharmacology & Physiology, University of Southampton, UK